Healthcare & Biotech

We have initiated coverage on Sonic Healthcare (SHL) with a price target of $33.70 and Buy recommendation.

We have initiated coverage on Trajan Group (TRJ) with a price target of $1.50 and a Buy recommendation.

PME’s growth in core radiology and cardiology services supports an upgraded Buy rating with a price target of $330.

We have initiated coverage on CSL Limited (CSL) with a price target of $345 and a Buy recommendation.

NEU released impressive efficacy and safety results from the first of four single-arm Phase 2 trials evaluating NNZ-2591 (n=18).